Delivery Order SPE2DB22D2005-SPE2DB24FJHQ4
Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $2,918.33, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LINZESS 72 MCG Capsule, a pharmaceutical product, with a completion date of May 15, 2023. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,069.09 firm fixed-price delivery order contract is for the supply of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables the efficient...
- This federal contract award, valued at $20,956.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of October 30, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of LINZESS 290 MCG CAPSULE medical products, with a ceiling value of $2,391.58 and a completion date of February 23, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award, valued at $2,653.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product LINZESS 290 MCG CAPSULE UU 30S, with a period of performance through December 6, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,325.03, is for the supply of LINZESS 290 MCG capsules. The award is under an Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a...
- This federal contract award is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $3,402.86 and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00. This IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,707.34 firm-fixed-price delivery order is for the pharmaceutical product LINZESS 145 MCG CAPSULE. The contract has an ultimate completion date of October 21, 2021. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as a primary...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LINZESS 290 MCG CAPSULE, a medication used to treat certain gastrointestinal conditions. The contract has a ceiling value of $3,379.10 and an ultimate completion date of June 11, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, with a ceiling value of $3,622.62 and a period of performance through May 17, 2023. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued...